Asia FX muted, dollar fragile as CPI data boosts Sept rate cut bets
Hilda Harris Piell, the Senior Managing Director and Chief Human Resources Officer at CME Group Inc. (NASDAQ:CME), recently sold 3,984 shares of the company’s Class A common stock. The shares were sold at an average price of $250.465, amounting to a total transaction value of approximately $997,852. Following this sale, Piell holds 27,046 shares directly. This transaction was reported in a Form 4 filing with the Securities and Exchange Commission. The company has maintained dividend payments for 23 consecutive years, with a current dividend yield of 4.3%. For deeper insights into CME Group’s financials and more exclusive tips, access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, CME Group reported a robust fourth-quarter 2024 performance, with adjusted earnings per share (EPS) of $2.52, surpassing the forecast of $2.48. The company also achieved a revenue milestone of $1.5 billion for the quarter, contributing to a total annual revenue of $6.1 billion, marking a 10% increase from the previous year. Following these earnings results, several analyst firms adjusted their outlook on CME Group. UBS raised its price target for the company to $290, maintaining a Buy rating, citing expectations of strong trading volumes and fee increases as revenue growth drivers. RBC Capital also increased its price target to $269, maintaining a Sector Perform rating, noting potential volume growth from macroeconomic uncertainties and strategic expansions. Keefe, Bruyette & Woods slightly adjusted their price target to $257, maintaining a Market Perform rating, following CME Group’s earnings that exceeded expectations. The firm’s analysis credited the earnings beat to higher transaction revenues and increased market data fees. Additionally, CME Group’s strategic initiatives, such as expanding its customer base and potential share buybacks, were highlighted as positive indicators for future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.